FDA Approves RSV Vaccine Abrysvo for Use During Pregnancy to Protect Infants
Abyrsvo is the first vaccine approved for pregnant individuals to prevent RSV disease in infants.
Diagnosis & Disease Information
FDA Fast Tracks Novel siRNA Therapy for Preeclampsia Treatment
The investigational therapy is designed to decrease the production of soluble fms-like tyrosine kinase-1 (sFLT1) mRNA isoforms in the placenta.
First Over-the-Counter Birth Control Pill Gets FDA Approval
Removing the prescription requirement improves access to an effective contraceptive method for women of all ages.
Postpartum Preeclampsia: Clinical Overview of Hypertensive Crisis
Timely recognition and treatment of postpartum preeclampsia is essential to improving morbidity and mortality in postpartum patients.
Chlamydia Infection: Silent Cause of Female Infertility
Studies link chlamydia to a high risk of female infertility. How should primary care providers assess for inflammation and tubal patency in affected patients?
Veozah Approved for Moderate to Severe Vasomotor Symptoms Due to Menopause
Veozah is an oral neurokinin 3 (NK3) receptor antagonist.
FDA Panel Supports Rx-to-OTC Switch of Progestin-Only Birth Control Pill
A decision on the OTC oral contraceptive pill is expected later this year.
Did Hospitals Violate EMTALA by Failing to Provide Abortion Care?
CMS investigates 2 hospitals for EMTALA violations related to abortion care for a pregnancy-related emergency.
FDA Sets Date to Discuss Over-the-Counter Birth Control Pill
If approved, Opill would be the first daily oral contraceptive pill available without a prescription.
Jemperli Granted Full Approval for dMMR Recurrent or Advanced Endometrial Cancer
The conversion to regular approval was based on data from an additional 141 patients with dMMR recurrent or advanced endometrial cancer who had progressed on or after a platinum-containing regimen.
- Loading...
Loading...
Loading... 
Loading...